new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Aventis Pharma S a
Aventis Pharma S a_20100114
  

Aventis Pharma S a patents

Recent patent applications related to Aventis Pharma S a. Aventis Pharma S a is listed as an Agent/Assignee. Note: Aventis Pharma S a may have other listings under different names/spellings. We're not affiliated with Aventis Pharma S a, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Aventis Pharma S a-related inventors




Date Aventis Pharma S a patents (updated weekly) - BOOKMARK this page
11/17/16Cabazitaxel and its use for treating cancer
12/31/15Cabazitaxel and its use for treating metastatic prostate cancers
04/30/15Novel antitumoral use of cabazitaxel
04/16/15Novel antitumoral use of cabazitaxel
03/12/15Mutations of the parkin gene, compositions, methods and uses
05/08/14Antitumour combinations containing a vegf inhibiting agent and irinotecan
03/13/14Pharmaceutical composition comprising ketoprofen
02/27/14Antitumoral combination comprising cabazitaxel and cisplatin
12/26/13Solid pharmaceutical composition comprising telithromycin
08/15/13Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
07/11/13Crystalline forms of dimethoxy docetaxel and methods for preparing the same
04/25/13Semuloparin for the extended prevention of a mortality and/or morbidity event in a patient having undergone hip fracture surgery
04/25/13Semuloparin for the prevention of a mortality and/or morbidity event in a patient undergoing major orthopedic surgery
04/25/13Semuloparin for use as an antithrombotic treatment in hip replacement surgery with improved safety in terms of clinically relevant bleedings and major bleedings
11/29/12Novel antitumoral use of cabazitaxel
11/01/12Compositions for topical application having androgenic actions
11/01/12Desmosterol-producing yeast strains and uses thereof
10/25/12Recombinant adenoviruses encoding the specific iodine transporter (nis)
05/17/12Compositions for oral adminstration of active principles requiring masking of taste
03/15/12Mutation of the parkin gene, compositions, methods and uses
10/27/11Antitumour compositions containing taxane derivatives
09/01/11Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
09/01/11New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
08/18/11Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
08/04/11Substituted pyrazolopyridines, compositions containing them, the production thereof, and their use
07/21/11Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
06/23/11Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
06/16/11Crystalline forms of dimethoxy docetaxel and methods for preparing the same
05/05/11Galenic applications of self-emulsifying mixtures of lipidic excipients
03/17/11Compositions for topical application having androgenic actions
03/03/11Combination comprising combretastatin and anticancer agents
02/24/11Novel method and intermediates for preparing 19-norsteroid compounds
01/27/11Taste masked oral composition of telithromycin
01/27/11New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
12/30/10Method of using enoxaparin for reducing the risk of death in acutely ill medical patients
12/09/10Novel taxoid-based compositions
10/07/10Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
09/30/10Oligosaccharides, preparation method and use thereof, and pharmaceutical compositions containing same
06/24/10Antitumour combinations containing a vegf inhibiting agent and irinotecan
06/24/10Novel process for the preparation of chiral compounds derived from hexanoic acid esters and intermediates used in the synthesis of chiral-2-(bromomethyl)-2-ethylhexanoic acid
05/06/10Yeast strains autonomously producing steroids
04/01/10Recombinant adenoviruses encoding the specific iodine transporter (nis)
01/14/10Compositions for oral adminstration of active principles requiring masking of taste
10/08/09Novel indole derivatives, preparation thereof as medicinal products and pharmaceutical compositions, and especially as kdr inhibitors
09/24/09Cholesterol-producing yeast strains and uses thereof
09/17/09Novel pyrrolo(2,3-b) pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors
09/10/09Chemical derivatives and their application as antitelomerase agents
08/27/09Heterocyclic compounds as inhibitors of beta-lactamases
08/06/09Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof
07/02/09Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
06/25/09Novel process for the preparation of chiral compounds derived from hexanoic acid esters and intermediates used in the synthesis of chiral 2-(bromomethyl)-2-ethylhexanoic acid
06/11/09Recombinant adenoviruses preparation and adenovirus banks
05/21/09Novel pyridazinone derivatives
04/09/09Compositions for topical application having androgenic actions
03/26/09Novel sulphur-containing cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
03/26/09Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
03/12/09Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
01/14/10Compositions for oral adminstration of active principles requiring masking of taste







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Aventis Pharma S a in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Aventis Pharma S a with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';